A novel complete autosomal recessive STAT1 LOF variant causes immunodeficiency with hemophagocytic lymphohistiocytosis-like hyperinflammation

Rheumatoid Arthritis

Bortezomib followed by autologous stem cell transplantation in a patient with rheumatoid arthritis: A case report and review of the literature.

Medicine (Baltimore).

Liu J, Li J, Chen M, Kuang L

doi: 10.1097/

Systemic Lupus Erythematosus

Post-transplant immune complex nephritis in a patient with systemic lupus erythematosus associated with ANCA vasculitis.

Pediatr Transplant.

Sanchez C, Rebolledo A, Gahona J, Rojas M, Jiménez R, Bojórquez A

doi: 10.1111/petr.12895.

Immunodeficiency

Improvement of common variable immunodeficiency using embryonic stem cell therapy in a patient with lyme disease: a clinical case report

Clin Case Rep.

Horowitz R, Freeman PR

doi: 10.1002/ccr3.1556.

Immunodeficiency

Immunological Features of Neuroblastoma Amplified Sequence Deficiency: Report of the First Case Identified Through Newborn Screening for Primary Immunodeficiency and Review of the Literature

Front Immunol.

Ricci S, Lodi L, Serranti D, Moroni M, Belli G, Mancano G, La Barbera A, Forzano G, Mangone G, Indolfi G, Azzari C

doi: 10.3389/fimmu.2019.01955.

Systemic Sclerosis

Severe thrombotic microangiopathy after autologous stem cell transplantation in systemic sclerosis: a case report

Rheumatology (Oxford)

Sharif MO, Leavis HL, van Paassen P, van Rhenen A, Timmermans SAMEG, Ton E, van Laar JM, Spierings J

doi: 10.1093/rheumatology/keab239

Immunodeficiency

Defining a new immune deficiency syndrome: MAN2B2-CDG

J Allergy Clin Immunol.

Verheijen J, Wong SY, Rowe JH, Raymond K, Stoddard J, Delmonte OM, Bosticardo M, Dobbs K, Niemela J, Calzoni E, Pai SY, Choi U, Yamazaki Y, Comeau AM, Janssen E, Henderson L, Hazen M, Berry G, Rosenzweig SD, Aldhekri HH, He M, Notarangelo LD, Morava E

doi: 10.1016/j.jaci.2019.11.016.

Melanoma and Skin Cancer

Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature

Melanoma Res.

Dudda M, Mann C, Heinz J, Schmidgen I, Weid F, Kühn M, Saloga J, Grabbe S, Loquai C

doi: 10.1097/CMR.0000000000000703.Visit the original publication at ncbi.nlm.nih.gov

Immunodeficiency

Natural Clearance of Prolonged VDPV Infection in a Child With Primary Immunodeficiency Disorder

Front Immunol.

Mohanty MC, Madkaikar MR, Desai M, Aluri J, Varose SY, Taur P, Sharma DK, Nalavade UP, Rane SV, Gupta M, Shabarish S, Dalvi A, Deshpande JM

doi: 10.3389/fimmu.2019.01567.

Immunodeficiency

Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy

Clin Immunol.

Grunebaum E, Reid B, Naqvi A, Hershfield MS, Kim VH, Muller MP, Hicks LK, Lee E, Betschel S, Roifman CM

doi: 10.1016/j.clim.2019.108321.

Related content

Bortezomib followed by autologous stem cell transplantation in a patient with rheumatoid arthritis: A case report and review of the literature.

Post-transplant immune complex nephritis in a patient with systemic lupus erythematosus associated with ANCA vasculitis.

Improvement of common variable immunodeficiency using embryonic stem cell therapy in a patient with lyme disease: a clinical case report

Immunological Features of Neuroblastoma Amplified Sequence Deficiency: Report of the First Case Identified Through Newborn Screening for Primary Immunodeficiency and Review of the Literature

Severe thrombotic microangiopathy after autologous stem cell transplantation in systemic sclerosis: a case report

Defining a new immune deficiency syndrome: MAN2B2-CDG

Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature

Natural Clearance of Prolonged VDPV Infection in a Child With Primary Immunodeficiency Disorder

Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy

Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy